Immix Biopharma (IMMX) Retained Earnings (2020 - 2026)
Quarterly results put Retained Earnings at -$114.5 million for Q1 2026, down 43.97% from a year ago — trailing twelve months through Mar 2026 was -$114.5 million (down 43.97% YoY), and the annual figure for FY2025 was $60160.0, up 5796.97%.
Immix Biopharma has reported Retained Earnings over the past 7 years, most recently at -$114.5 million for Q1 2026.
- Retained Earnings reached -$114.5 million in Q1 2026 per IMMX's latest filing, down from $60160.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $192051.0 in Q3 2024 and bottomed at -$114.5 million in Q1 2026.
- Median Retained Earnings over the past 5 years was -$1056.0 (2024), compared with a mean of -$30.9 million.
- Peak annual rise in Retained Earnings hit 5796.97% in 2025, while the deepest fall reached 88888.8% in 2025.
- Over 5 years, Retained Earnings stood at $87021.0 in 2022, then tumbled by 61477.48% to -$53.4 million in 2023, then surged by 100.0% to -$1056.0 in 2024, then skyrocketed by 5796.97% to $60160.0 in 2025, then crashed by 190508.86% to -$114.5 million in 2026.
- Business Quant data shows Retained Earnings for IMMX at -$114.5 million in Q1 2026, $60160.0 in Q4 2025, and -$93.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 36.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 130.89 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | -114.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -114.55 Mn |
| Dec 31, 2025 | 60,160.00 |
| Sep 30, 2025 | -93.78 Mn |
| Jun 30, 2025 | 65,032.00 |
| Mar 31, 2025 | -79.57 Mn |
| Dec 31, 2024 | -1,056.00 |
| Sep 30, 2024 | 192,051.00 |
| Jun 30, 2024 | -63.06 Mn |
| Mar 31, 2024 | 89,614.00 |
| Dec 31, 2023 | -53.41 Mn |
| Sep 30, 2023 | -48.32 Mn |
| Jun 30, 2023 | 80,882.00 |
| Mar 31, 2023 | -40.46 Mn |
| Dec 31, 2022 | 87,021.00 |
| Sep 30, 2022 | 62,055.00 |
| Jun 30, 2022 | -32.65 Mn |
| Mar 31, 2022 | 140,995.00 |
| Dec 31, 2021 | 125,408.00 |
| Dec 31, 2020 | 131,861.00 |